Gabaeron

San Francisco, United States

Gabaeron is a biopharmaceutical business that develops therapeutics for neurological illnesses based on stem cells and small chemicals.

$3.0M raised

Dec 2024

Series A

Top Investors

Zhongzhi Pharmaceutical Holdings

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Gabaeron raised?

Gabaeron has raised $3.0M in total funding. The most recent round was Series A. The last funding was announced in December 2024.

Who are Gabaeron's investors?

Gabaeron's investors include Zhongzhi Pharmaceutical Holdings.

Where is Gabaeron headquartered?

Gabaeron is headquartered in San Francisco, United States.

What does Gabaeron do?

Gabaeron is a biopharmaceutical business that develops therapeutics for neurological illnesses based on stem cells and small chemicals.

What stage is Gabaeron at?

Gabaeron is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 21, 2024.

MLA

"Gabaeron — Funding & Investors." VCBacked, December 21, 2024, https://www.vcbacked.co/company/gabaeron. Accessed June 17, 2026.

APA

VCBacked. (2024). Gabaeron — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/gabaeron

Wikipedia (cite web)

{{cite web |title=Gabaeron — Funding & Investors |url=https://www.vcbacked.co/company/gabaeron |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 21, 2024.